Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Wave Life Sci Ord Sh (WVE)

Wave Life Sci Ord Sh (WVE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Wave Life Sciences Announces Oral Presentation of Preclinical Data Supporting WVE-007’s Mechanism (INHBE) to Reduce Fat, Preserve Muscle, and Induce Healthy Weight Loss at ADA's Annual Scientific Sessions

WVE : 7.78 (-0.77%)
Wave Life Sciences to Present at 2025 Jefferies Global Healthcare Conference

WVE : 7.78 (-0.77%)
Wave Life Sciences Announces Appointment of Dr. Christopher Wright as Chief Medical Officer

WVE : 7.78 (-0.77%)
Wave Life Sciences: Q1 Earnings Snapshot

Wave Life Sciences: Q1 Earnings Snapshot

WVE : 7.78 (-0.77%)
Wave Life Sciences Reports First Quarter 2025 Financial Results and Provides Business Update

WVE : 7.78 (-0.77%)
Wave Life Sciences First Quarter 2025 Financial Results Scheduled for May 8, 2025

WVE : 7.78 (-0.77%)
Wave Life Sciences Announces Positive Data from FORWARD-53 Clinical Trial in DMD Including Significant Functional Benefit and Reversal of Muscle Damage after 48 Weeks of Dosing with WVE-N531

WVE : 7.78 (-0.77%)
Wave Life Sciences: Q4 Earnings Snapshot

Wave Life Sciences: Q4 Earnings Snapshot

WVE : 7.78 (-0.77%)
Wave Life Sciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

WVE : 7.78 (-0.77%)
Wave Life Sciences Fourth Quarter and Full Year 2024 Financial Results Scheduled for March 4, 2025

WVE : 7.78 (-0.77%)

Barchart Exclusives

Up 80% in the Last Year, Is Shopify Stock Stalling Out or Getting Ready for Its Next Surge?
Shopify is successfully executing its strategy, but the road ahead is not smooth. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar